Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Marc Veyrier"'
Continuité médicamenteuse après une hospitalisation en soins de suite et de réadaptation gériatrique
Publikováno v:
Soins Gérontologie. 27:39-45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95466fe0e5f8355862be9a0e42b8421e
https://doi.org/10.1016/j.sger.2021.11.010
https://doi.org/10.1016/j.sger.2021.11.010
Autor:
Clément Delage, Léa Darnaud, Bruno Etain, Marina Vignes, Tu-Ky Ly, Alexia Frapsauce, Marc Veyrier, Marine Delavest, Emeline Marlinge, Vincent Hennion, Manon Meyrel, Aude Jacob, Margot Chouchana, Julie Smati, Guillaume Pataud, Nihel Khoudour, Jean-Eudes Fontan, Laurence Labat, Frank Bellivier, Célia Lloret-Linares, Xavier Declèves, Vanessa Bloch
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 11; Pages: 1869
Altered cytochromes P450 enzymes (CYP) and P-glycoprotein transporter (P-gp) activity may explain variabilities in drug response. In this study, we analyzed four years of phenotypic assessments of CYP/P-gp activities to optimize pharmacotherapy in ps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d488bcf8fd501470cdefa9df486b49e8
https://pubmed.ncbi.nlm.nih.gov/36579580
https://pubmed.ncbi.nlm.nih.gov/36579580
Publikováno v:
Soins. Gerontologie. 27(153)
After one year of practice, the medication reconciliation approach in follow-up and rehabilitation care was evaluated. The aim of the activity was to identify changes in treatment (CT). Three hundred and two patients benefited from the process. Some
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3f25e65dfb1884e91d420793bca4fd8e
https://pubmed.ncbi.nlm.nih.gov/35120721
https://pubmed.ncbi.nlm.nih.gov/35120721
Autor:
Marc Veyrier, C. Karczewski, Vanessa Bloch, F. Iskra, M.L. Vignes, Hélène Barreteau, L. Kubiak, P. Cavagna, L. Nicolas
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 54:145-155
Resume Introduction L’automatisation de la dispensation individuelle nominative induit des changements de pratique sur l’ensemble du circuit du medicament, c’est pourquoi l’integration d’un automate doit etre anticipee. Une analyse prelimin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3376197da366e66059f881920edbe222
https://doi.org/10.1016/j.phclin.2018.10.057
https://doi.org/10.1016/j.phclin.2018.10.057
Autor:
Benoit Visseaux, Juliette Kauv, Jean-François Timsit, Quentin Le Hingrat, Minh Patrick Lê, Gilles Peytavin, Lila Bouadma, Etienne de Montmollin, Paul-Henri Wicky, Diane Descamps, Juliette Patrier, Cédric Laouénan, Marc Veyrier, Romain Sonneville, Pierre Jaquet
Publikováno v:
Journal of Antimicrobial Chemotherapy
Background The combination lopinavir/ritonavir is recommended to treat HIV-infected patients at the dose regimen of 400/100 mg q12h, oral route. The usual lopinavir trough plasma concentrations are 3000–8000 ng/mL. A trend towards a 28 day mortalit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c48c3682fc77ca41e52c7137648d75e
Autor:
Hélène Barreteau, Pauline Cavagna, Vanessa Bloch, Julien Azuar, Maeva Fortias, Louise Nicolas, Franck Bellivier, François Naccache, Thomas Barré, Marc Veyrier, Florence Vorspan
Publikováno v:
Therapies. 73:495-500
Summary Intranasal naloxone aims at preventing opioid overdose related deaths in active drug users. In France, it has been available since July 2016 through a temporary approval which requires a hospital-based pharmacy and a nominative registration o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::240e0521186f4e83cb633706cc42f1bd
https://doi.org/10.1016/j.therap.2018.03.003
https://doi.org/10.1016/j.therap.2018.03.003
Autor:
Minh Patrick Lê, Jade Ghosn, Benoit Visseaux, Marie-Paule Chauveheid, Gilles Peytavin, Juliette Kauv, Quentin Le Hingrat, Laurent Massias, Marc Veyrier, Diane Descamps
Publikováno v:
Journal of Antimicrobial Chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bcbd36a82e91a7eaf512ba726be24b4
https://doi.org/10.1093/jac/dkaa213
https://doi.org/10.1093/jac/dkaa213
Publikováno v:
Journal of Clinical Psychopharmacology. 39:87-88
To the EditorsThe first evidence based on case reports and open-label pilot studies has revealed a potential higher risk of psychiatric adverse effects associated with the use of levetiracetam, a first-line treatment for generalized tonic-clonic seiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52b0c885b9e2cab9edc81a7f7cd34b2b
https://doi.org/10.1097/jcp.0000000000000978
https://doi.org/10.1097/jcp.0000000000000978
Autor:
Thomas, Barré, Florence, Vorspan, Maeva, Fortias, Marc, Veyrier, Pauline, Cavagna, Julien, Azuar, Louise, Nicolas, François, Naccache, Hélène, Barreteau, Franck, Bellivier, Vanessa, Bloch
Publikováno v:
Therapie. 73(6)
Intranasal naloxone aims at preventing opioid overdose related deaths in active drug users. In France, it has been available since July 2016 through a temporary approval which requires a hospital-based pharmacy and a nominative registration of each p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5bf5765744941f955a451262da98af53
https://pubmed.ncbi.nlm.nih.gov/29680374
https://pubmed.ncbi.nlm.nih.gov/29680374
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 54:86
Introduction La melatonine est une hormone impliquee dans les rythmes circadiens. Une specialite a base de Melatonine a liberation prolongee (MLP) 2 mg est disponible pour les troubles du sommeil chez les plus de 55 ans. L’objectif etait de realise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63ca4c377f845af73e35e8d7ee8aefc8
https://doi.org/10.1016/j.phclin.2018.10.017
https://doi.org/10.1016/j.phclin.2018.10.017